Skip to Main Content

Author Details

Amit Mehta
Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
2014
9
7
PMIDPaper TitleJournal TitlePublished Year
25405562Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas.Ann Surg2016
25405562Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas.Ann Surg2016
25488748miR30a inhibits LOX expression and anaplastic thyroid cancer progression.Cancer Res2015
25488748miR30a inhibits LOX expression and anaplastic thyroid cancer progression.Cancer Res2015
25968622Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing's Syndrome.Ann Surg Oncol2015
25945839Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.Oncotarget2015
25944801Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.Clin Cancer Res2015
25940539Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.Oncotarget2015
25972243Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.Endocr Relat Cancer2015
26451910Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome.J Clin Endocrinol Metab2015
26451910Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome.J Clin Endocrinol Metab2015
25972243Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.Endocr Relat Cancer2015
25945839Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.Oncotarget2015
25968622Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing's Syndrome.Ann Surg Oncol2015
25944801Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer.Clin Cancer Res2015
25940539Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.Oncotarget2015
25444225Hyperparathyroidism-jaw tumor syndrome: Results of operative management.Surgery2014
25444225Hyperparathyroidism-jaw tumor syndrome: Results of operative management.Surgery2014
  • 1 - 18 of 18

Recommended Authors

Frederick National Laboratory for Cancer Research, National Institutes of Health
Career Start Year 2014
Number of shared co-authors 11
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Georgia Cancer Center, Augusta University
Career Start Year 2011
Number of shared co-authors 15
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year 2010
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 0
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 0
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 0
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 1
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 0
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 3
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 0
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 1
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
The Ohio State University College of Medicine and Comprehensive Cancer Center
Career Start Year 1991
Number of shared co-authors 1
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Stanford University School of Medicine
Co-authored papers 9
The University of Texas at Austin
Co-authored papers 6
Center for Cancer Research
Co-authored papers 5
National Institute of Child Health and Development
Co-authored papers 5
Jiangsu University Zhenjiang 212013
Co-authored papers 4
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Co-authored papers 3
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 3
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 2
Johns Hopkins University
Co-authored papers 2
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 2
Mayo Clinic Jacksonville
Co-authored papers 2
Mayo Clinic School of Medicine, Mayo Clinic
Co-authored papers 2
The University of North Carolina
Co-authored papers 2
Department of Biochemistry and Howard Hughes Medical Institute, Stanford University
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Sichuan University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1